Annual Conference on Tularemia

兔热病年会

• 批准号: 7485812
• 负责人: DENNIS W METZGER
• 金额: --
• 依托单位: ALBANY MEDICAL COLLEGE
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-09-01 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7485812
• 关键词: Bathing; Categories; Collaborations; Communities; Country; Educational workshop; England; Francisella tularensis; Funding; Future; Goals; Infection; International; Knowledge; Laboratories; Laboratory Study; National Institute of Allergy and Infectious Disease; Numbers; Organism; Participant; Pathogenesis; Research; Research Personnel; Resort; Resources; Time; Tularemia; United States; base; biothreat; experience; member; symposium; vaccine development

Francisella tularensis is a category A biothreat agent. Since 9/11/2001, the number of laboratories studying this organism has expanded dramatically. Thus, it is important that investigators (new and experienced in the field) meet on an annual basis to share their findings and define future research goals. The proposed Tularemia Conference will provide, on an annual basis, an international forum for tularemia researchers to interact and share their knowledge. The specific goal of this meeting is to provide an opportunity for members of the tularemia community, including new investigators and trainees, to present and discuss their research, exchange ideas, and develop collaborations. This conference has occurred five times previously, four times (at 3-4 year intervals) as the "International Conference on Tularemia", the last occurring in 2003 in Bath, England. The fifth meeting, the NIAID Tularemia Workshop at the Rocky Mountain Laboratories, Hamilton, MT, was held in October of 2004 to facilitate a more timely exchange of information between new and experienced investigators. The 2003 meeting in Bath England included approximately 125 participants from around the world. The 2004 meeting in Hamilton, MT, had approximately 115 participants. The next meeting will be held November 6-8, 2005, at the Jiminy Peak Mountain Resort in Hancock, MA. It is anticipated that the 2005 meeting will include over 125 participants from the United States, as well as other countries. This will be followed by an International Conference on Tularemia in November, 2006 and an annual meeting/workshop thereafter. The focus of these meetings will be on mechanisms of F. tularensis infection and pathogenesis, as well as vaccine development. Funds requested in this application will be used primarily to allow new investigators with limited resources (e.g., R21 recipients) as well as trainees, to participate in these meetings.

图拉氏弗朗西斯菌是一种A类生物制剂。自2001年9月11日以来，研究这种微生物的实验室数量急剧增加。因此，重要的是，研究人员(该领域的新手和有经验的)每年举行会议，分享他们的发现并确定未来的研究目标。拟议的图拉热病会议将每年为图拉热病研究人员提供一个国际论坛，以交流和分享他们的知识。这次会议的具体目标是为图拉热病社区的成员，包括新的调查人员和受训人员提供一个机会，介绍和讨论他们的 研究、交流思想和开展协作。这一会议以前已经举行过五次，其中四次(每隔3-4年举行一次)是“图拉热症国际会议”，最后一次是2003年在英国巴斯举行的。第五次会议是2004年10月在密歇根州汉密尔顿落基山实验室举行的NIAID图拉热症研讨会，目的是促进新手和有经验的研究人员更及时地交流信息。2003年在英国巴斯举行的会议有来自世界各地的大约125名与会者参加。2004年在密歇根州汉密尔顿举行的会议大约有115人参加。下一次会议将于2005年11月6日至8日在马萨诸塞州汉考克的吉米尼山顶度假村举行。预计2005年会议将有来自美国和其他国家的125多名与会者参加 国家。随后将于2006年11月举行图拉热病问题国际会议，之后将举行年度会议/讲习班。这些会议的重点将是图拉氏肺吸虫的感染机制和发病机制，以及疫苗的开发。本申请申请的资金将主要用于允许资源有限的新调查员(例如，R21获奖者)以及受训人员参加这些会议。